Skip to main content
. 2021 May 13;9(5):580. doi: 10.3390/healthcare9050580

Table 2.

Diabetes duration, haemoglobin A1c, blood pressure, and diabetic retinopathy of study participants.

Total (n = 2510) Hypertensives with T2DM (n = 1495) Normotensives with T2DM (n = 1015) p-Value
Duration of diabetes, years 8.56 (7.10) 9.00 (7.22) 7.92 (6.87) <0.001
Duration of diabetes (groups)
<4 years 768 (30.6%) 433 (29.0%) 335 (33.0%) 0.004
4–11 years 1023 (40.8%) 598 (40.0%) 425 (41.9%)
≥12 years 719 (28.6%) 464 (31.0%) 255 (25.1%)
HbA1c, % 7.02 (1.43) 6.97 (1.38) 7.10 (1.51) 0.023
HbA1c (groups)
<6.5% 1054 (42.0%) 629 (42.1%) 425 (41.9%) 0.920
≥6.5% 1456 (58.0%) 866 (57.9%) 590 (58.1%)
Systolic BP, mmHg 134.82 (18.74) 143.39 (17.86) 122.14 (11.40) <0.001
Diastolic BP, mmHg 70.45 (10.47) 72.89 (10.97) 66.80 (8.44) <0.001
Presence of DR
No 1960 (78.1%) 1155 (77.3%) 805 (79.3%) 0.222
Yes 550 (21.9%) 340 (22.7%) 210 (20.7%)
Grading of DR 1
Mild NPDR 119 (22.3%) 61 (18.4%) 58 (28.6%) 0.081
Moderate NPDR 342 (64.0%) 222 (67.1%) 120 (59.1%)
Severe NPDR 47 (8.8%) 30 (9.1%) 17 (8.4%)
Proliferative DR 26 (4.9%) 18 (5.4%) 8 (3.9%)

1 Patients with ungradable images for diabetic retinopathy due to small pupils, media opacities, or poor image quality were excluded (n = 16). T2DM, type 2 diabetes mellitus; BP, blood pressure; HbA1c, haemoglobin A1c; DR, diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy. Data are presented as mean (standard deviation) or n (%), where appropriate. Column percentages were derived from the total number in the corresponding column.